144 related articles for article (PubMed ID: 36779209)
1. Systemic thrombolytics as rescue therapy for COVID-19 patients with acute respiratory distress syndrome: A retrospective observational study.
Ashwathappa PG; Jacob I; Rangappa P; Rao K
Int J Crit Illn Inj Sci; 2022; 12(4):197-203. PubMed ID: 36779209
[TBL] [Abstract][Full Text] [Related]
2. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study.
Al Sulaiman K; Korayem GB; Altebainawi AF; Al Harbi S; Alissa A; Alharthi A; Kensara R; Alfahed A; Vishwakarma R; Al Haji H; Almohaimid N; Al Zumai O; Alrubayan F; Asiri A; Alkahtani N; Alolayan A; Alsohimi S; Melibari N; Almagthali A; Aljahdali S; Alenazi AA; Alsaeedi AS; Al Ghamdi G; Al Faris O; Alqahtani J; Al Qahtani J; Alshammari KA; Alshammari KI; Aljuhani O
Crit Care; 2022 Oct; 26(1):304. PubMed ID: 36192801
[TBL] [Abstract][Full Text] [Related]
4. Breathing pattern, accessory respiratory muscles work, and gas exchange evaluation for prediction of NIV failure in moderate-to-severe COVID-19-associated ARDS after deterioration of respiratory failure outside ICU: the COVID-NIV observational study.
Yaroshetskiy AI; Merzhoeva ZM; Tsareva NA; Trushenko NV; Nuralieva GS; Konanykhin VD; Krasnoshchekova AP; Avdeev SN
BMC Anesthesiol; 2022 Oct; 22(1):307. PubMed ID: 36183064
[TBL] [Abstract][Full Text] [Related]
5. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
[TBL] [Abstract][Full Text] [Related]
6. Impact of intravenous lidocaine on clinical outcomes of patients with ARDS during COVID-19 pandemia (LidoCovid): A structured summary of a study protocol for a randomised controlled trial.
Muller M; Lefebvre F; Harlay ML; Glady L; Becker G; Muller C; Aberkane O; Tawk M; Julians M; Romoli A; Hecketsweiler S; Schneider F; Pottecher J; Chamaraux-Tran TN
Trials; 2021 Feb; 22(1):131. PubMed ID: 33573681
[TBL] [Abstract][Full Text] [Related]
7. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
[TBL] [Abstract][Full Text] [Related]
8. Omega-3 polyunsaturated fatty acids in critically ill patients with acute respiratory distress syndrome: A systematic review and meta-analysis.
Langlois PL; D'Aragon F; Hardy G; Manzanares W
Nutrition; 2019 May; 61():84-92. PubMed ID: 30703574
[TBL] [Abstract][Full Text] [Related]
9. Study of alteplase for respiratory failure in severe acute respiratory syndrome coronavirus 2/COVID-19: Study design of the phase IIa STARS trial.
Moore HB; Barrett CD; Moore EE; Jhunjhunwala R; McIntyre RC; Moore PK; Wang J; Hajizadeh N; Talmor DS; Sauaia A; Yaffe MB
Res Pract Thromb Haemost; 2020 Aug; 4(6):984-996. PubMed ID: 32838109
[TBL] [Abstract][Full Text] [Related]
10. Best evidence in critical care medicine: The role of neuromuscular blocking drugs in early severe acute respiratory distress syndrome.
Needham CJ; Brindley PG
Can J Anaesth; 2012 Jan; 59(1):105-8. PubMed ID: 22042702
[TBL] [Abstract][Full Text] [Related]
11. Broadening the Berlin definition of ARDS to patients receiving high-flow nasal oxygen: an observational study in patients with acute hypoxemic respiratory failure due to COVID-19.
van der Ven FLIM; Valk CMA; Blok S; Brouwer MG; Go DM; Lokhorst A; Swart P; van Meenen DMP; Paulus F; Schultz MJ;
Ann Intensive Care; 2023 Jul; 13(1):64. PubMed ID: 37452196
[TBL] [Abstract][Full Text] [Related]
12. Study of Alteplase for Respiratory Failure in SARS-CoV-2 COVID-19: A Vanguard Multicenter, Rapidly Adaptive, Pragmatic, Randomized Controlled Trial.
Barrett CD; Moore HB; Moore EE; Wang J; Hajizadeh N; Biffl WL; Lottenberg L; Patel PR; Truitt MS; McIntyre RC; Bull TM; Ammons LA; Ghasabyan A; Chandler J; Douglas IS; Schmidt EP; Moore PK; Wright FL; Ramdeo R; Borrego R; Rueda M; Dhupa A; McCaul DS; Dandan T; Sarkar PK; Khan B; Sreevidya C; McDaniel C; Grossman Verner HM; Pearcy C; Anez-Bustillos L; Baedorf-Kassis EN; Jhunjhunwala R; Shaefi S; Capers K; Banner-Goodspeed V; Talmor DS; Sauaia A; Yaffe MB
Chest; 2022 Mar; 161(3):710-727. PubMed ID: 34592318
[TBL] [Abstract][Full Text] [Related]
13. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial.
Gorman E; Shankar-Hari M; Hopkins P; Tunnicliffe WS; Perkins GD; Silversides J; McGuigan P; Jackson C; Boyle R; McFerran J; McDowell C; Campbell C; McFarland M; Smythe J; Thompson J; Williams B; Curley G; Laffey JG; Clarke M; O'Kane C; McAuley DF
Trials; 2020 Jun; 21(1):462. PubMed ID: 32493473
[TBL] [Abstract][Full Text] [Related]
14. Rescue therapy with thrombolysis in patients with severe COVID-19-associated acute respiratory distress syndrome.
Price LC; Garfield B; Bleakley C; Keeling AGM; Mcfadyen C; McCabe C; Ridge CA; Wort SJ; Price S; Arachchillage DJ
Pulm Circ; 2020; 10(4):2045894020973906. PubMed ID: 33403100
[TBL] [Abstract][Full Text] [Related]
15. Mortality in patients with COVID-19 versus non-COVID-19- related acute respiratory distress syndrome: A single center retrospective observational cohort study.
Hsieh YH; Chang HT; Wang PH; Chang MY; Hsu HS
PLoS One; 2023; 18(6):e0286564. PubMed ID: 37267339
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of corticosteroids in non-intensive care unit patients with COVID-19 pneumonia from the New York Metropolitan region.
Majmundar M; Kansara T; Lenik JM; Park H; Ghosh K; Doshi R; Shah P; Kumar A; Amin H; Chaudhari S; Habtes I
PLoS One; 2020; 15(9):e0238827. PubMed ID: 32903258
[TBL] [Abstract][Full Text] [Related]
17. The PANDORA Study: Prevalence and Outcome of Acute Hypoxemic Respiratory Failure in the Pre-COVID-19 Era.
Villar J; Mora-Ordoñez JM; Soler JA; Mosteiro F; Vidal A; Ambrós A; Fernández L; Murcia I; Civantos B; Romera MA; Mira A; Díaz-Domínguez FJ; Parrilla D; Martínez-Carmona JF; Martínez D; Pita-García L; Robaglia D; Bueno-González A; Sánchez-Ballesteros J; Pereyra ÁE; Hernández M; Chamorro-Jambrina C; Cobeta P; González-Luengo RI; Montiel R; Nogales L; Fernández MM; Arocas B; Valverde-Montoro Á; Del Saz-Ortiz AM; Olea-Jiménez V; Añón JM; Rodríguez-Suárez P; Fernández RL; Fernández C; Szakmany T; González-Martín JM; Ferrando C; Kacmarek RM; Slutsky AS
Crit Care Explor; 2022 May; 4(5):e0684. PubMed ID: 35510152
[TBL] [Abstract][Full Text] [Related]
18. Impact of Inhaled Epoprostenol in Patients on COVID-19 Acute Respiratory Distress Syndrome (ARDS).
Nguyen S; Chromi S; Decerbo M; Dey S; McCoy J; Murawsky J
HCA Healthc J Med; 2023; 4(2):181-185. PubMed ID: 37424973
[TBL] [Abstract][Full Text] [Related]
19. A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial.
McEvoy NL; Clarke JL; Mc Elvaney OJ; Mc Elvaney OF; Boland F; Hyland D; Geoghegan P; Donnelly K; Friel O; Cullen A; Collins AM; Fraughen D; Martin-Loeches I; Hennessy M; Laffey JG; Mc Elvaney NG; Curley GF
Trials; 2021 Apr; 22(1):288. PubMed ID: 33874981
[TBL] [Abstract][Full Text] [Related]
20. Rapidly improving acute respiratory distress syndrome in COVID-19: a multi-centre observational study.
Gavrielatou E; Vaporidi K; Tsolaki V; Tserlikakis N; Zakynthinos GE; Papoutsi E; Maragkuti A; Mantelou AG; Karayiannis D; Mastora Z; Georgopoulos D; Zakynthinos E; Routsi C; Zakynthinos SG; Schenck EJ; Kotanidou A; Siempos II
Respir Res; 2022 Apr; 23(1):94. PubMed ID: 35422037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
